@article{Poveda:2021,
author
=
"A.Poveda and A.Floquet and J.Ledermann and R.Asher and R.Penson and A.Oza and J.Korach and T.Huzarski and S.Pignata and M.Friedlander and A.Baldoni and T.Park-Simon and K.Tamura and G.Sonke and A.Lisyanskaya and J.Kim and E.Filho and T.Milenkova and E.Lowe and P.Rowe and I.Vergote and E.Pujade-Lauraine and t.investigator",
title
=
"Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial",
journal
=
"The Lancet Oncology",
volume
=
"Vol. 22",
number
=
"Iss. 5",
pages
=
"620--631",
year
=
"2021",
}